Relationship between HLA-DRB 1 genotypes and efficacy of oral type II collagen treatment using chicken cartilage soup in rheumatoid arthritis

Japanese Journal of Clinical Immunology

Volumn 20, Issue 1, 1997, Pages 44-51

  Toda, Yoshitaka ^a   Takemura, Seisuke ^a   Morimoto, Tadanobu ^a   Ogawa, Ryoukei ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Collagen; Immunogenetics; Rheumatoid Arthritis

Indexed keywords

COLLAGEN; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

AGED; ANIMAL; ARTICLE; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RHEUMATOID ARTHRITIS;

ADMINISTRATION, ORAL; AGED; ANIMALS; ARTHRITIS, RHEUMATOID; CHICKENS; COLLAGEN; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED;

EID: 0031067807     PISSN: 09114300     EISSN: 13497413     Source Type: Journal    
DOI: 10.2177/jsci.20.44     Document Type: Article

References (17)

1. D.E., Trentham, A.S., Townes, A.H., Kang, Autoimmunity to type II collagen: An experimental model of arthritis, J. Exp. Med., (1977), 146, 857-868
2. Courtenay, J.S., Dallman, M.J., Dayan, A.D.: Immunization aging heterologous type II collagen induced arthritis in mice. Nature, 283: 666–667, 1980.
3. Kobayashi, S., Terato, K., Yoshida, H. et al.: Suppression of type II collagen-induced arthritis by monoclonal antibodies. Arthritis Rheum., 34: 48–54, 1991.
4. N.A., Staines, T., Hardingham, M., Smith, et al., Collagen-induced arthritis in rat: Modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum, Immunology, (1981), 44, 737-744
5. Englet, M.E., Landes, M.J., Oronsky, A.L. et al.: Suppression of type II collagen-induced arthritis by the intravenous administration of type II collagen or its constituent peptide α-1 (II) CB 10. Cell Immunol., 87: 357–365, 1984.
6. Trentham, D.E., Dynesius-Trentham, R.A., Ovav, E.J. et al.: Effect of oral administration of type II collagen on rheumatoid arthritis. Science, 261: 1727–1730, 1993.
7. Cook, A.D., Rowley, M.J., Mackay I. et al.: Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression. Arthritis Rheum. 39: 1720–1727, 1996.
8. Terato, K., DeArmey, D.A., Ye, X.J. et al.: The mechanism of autoantibody formation to cartilage in rheumatoid arthritis. Clin. Immunol. Immunopathol. 79: 142–154, 1996.
9. Sieper, J., Kary, S., Sorensen, H. et al.: Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo - controlled, randomized trial. Arthritis Rheum. 39: 41–51, 1996.
10. Arnett, F.C., Edworthy, S.M., Bloch, D.A. et al.: The American rheumatism association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum. 31: 315–324, 1988.
11. Weber, K., Osborn, M.: The reliability of molecular weight determination by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Bio. Chem., 244: 4406–4412, 1969.
12. Laemmli, U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage. Nature, 227: 680–685, 1970.
13. Terato, K., Shimozuru, Y., Katayama, K. et al.: Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum., 33: 1493–1500, 1990.
14. Kaneshige, H., Murayama, T., Hirasawa, M. et al.: Rapid and practical HLA class II genotyping by reverse dot blotting. Transplant. Proc, 25: 194–198, 1993.
15. Higgins, P.J., Weiner, H.L.: Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J. Immunol., 140: 445–450, 1988.
16. Nussenblatt, R.B., Caspi, R.R., Mahdi, R. et al.: Inhibition of Santigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol., 144: 1689–1695, 1990.
17. Toda, Y., Minamikawa, Y., Akagi, S. et al.: Rheumatoid susceptible allele of HLA-DRB 1 are genetically recessive to non-susceptible alleles in the progression of bone destruction in the wrists and fingers of patients with RA. Ann. Rheum. Dis., 53: 587–592, 1994.